Skip to main content
BIOME AUSTRALIA LIMITED logo

BIOME AUSTRALIA LIMITED — Investor Relations & Filings

Ticker · BIO ISIN · AU0000184137 ASX Manufacturing
Open in API
Filings indexed 302 across all filing types
Latest filing 2025-09-23 AGM Information
Country AU Australia
Listing ASX BIO

About BIOME AUSTRALIA LIMITED

https://www.biomeaustralia.com

Biome Australia Limited is a microbiome health company specializing in the development and distribution of evidence-based probiotics and complementary medicines. The company focuses on translating microbiome science into accessible healthcare solutions through its flagship brand, Activated Probiotics. Its product portfolio consists of condition-specific formulations designed to address various health areas, including digestive health, immune system support, bone density, and mental wellbeing via psychobiotics. Biome Australia prioritizes clinical research and collaborates with global experts to ensure the efficacy of its formulations. The company’s distribution strategy centers on a network of community pharmacies and independent health practitioners, providing professional-grade supplements to the retail and clinical markets.

Recent filings

Filing Released Lang Actions
Date of AGM and Closing Date for Director Nominations 2 pages 285.8KB
AGM Information Classification · 95% confidence The document is an ASX announcement dated 24 September 2025 regarding the date of the Annual General Meeting (AGM) and the closing date for director nominations. It references the upcoming AGM date and the process for director nominations but does not contain any AGM materials, minutes, or presentations. The document is short (2291 characters) and serves as a notification about the AGM date and nomination deadline rather than the AGM content itself. According to the classification rules, announcements about AGM dates and related procedural information fall under AGM Information (AGM-R).
2025-09-23 English
Q1 FY26 Revenue Guidance 3 pages 303.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 3 September 2025, titled 'Revenue Guidance'. It provides a forecast for Q1 FY26 sales revenue expected to surpass $5.5 million, indicating forward-looking financial information. The text is relatively short (4813 characters) and does not contain actual financial statements or detailed financial results. It is a guidance announcement about expected revenue performance rather than a full financial report or earnings release. There is no indication of it being a transcript, management report, or regulatory filing beyond the announcement itself. Therefore, the document is best classified as a Capital/Financing Update (CAP) because it provides an update on expected financial performance and revenue guidance, which relates to the company's financial outlook and capital expectations.
2025-09-02 English
Biome Secures New Zealand Pharmacy Deal 5 pages 298.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 2 September 2025, detailing a strategic partnership between Biome Australia Limited and Green Cross Health New Zealand. It focuses on business expansion, market access, and product launch plans. The content includes market data, strategic alignment, and forward-looking statements but does not contain financial statements, audit information, or regulatory certifications. It is a corporate announcement about a capital or business development initiative rather than a financial report or regulatory filing. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to strategic partnership and market expansion which impacts the company's capital and business growth.
2025-09-01 English
Biome Secures Distribution with Mecca and GoVita 5 pages 305.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 28 August 2025 from Biome Australia Limited. It details new strategic distribution partnerships with Mecca and Go Vita for their Activated Probiotics product range. The content focuses on business development, distribution agreements, and market expansion. There are no financial statements, quarterly or annual results, nor any regulatory filings or voting results. The document is a corporate announcement about a capital or business update related to distribution channels and market strategy. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. The best fitting category is Capital/Financing Update (CAP) as it relates to strategic business development and distribution expansion, which impacts the company's capital and market positioning.
2025-08-27 English
Preliminary Final Report 25 pages 287.8KB
Annual Report Classification · 95% confidence The document is titled 'Biome Australia Limited Appendix 4E Preliminary final report' and covers the full fiscal year ended 30 June 2025. It includes detailed financial statements such as the statement of profit or loss, statement of financial position, statement of changes in equity, and statement of cash flows, along with notes to the financial statements. The report contains comprehensive financial data and analysis for the full year, including revenues, profits, assets, liabilities, and equity changes. The presence of a preliminary final report with full financial statements and notes indicates this is an annual financial report. Appendix 4E is a regulatory filing used in Australia for preliminary final reports, which are equivalent to annual reports but often preliminary before audit completion. Given the detailed financial data and the full-year coverage, this document fits the definition of an Annual Report (10-K equivalent). FY 2025
2025-08-26 English
Financial Year 2025 Preliminary Results 5 pages 323.7KB
Annual Report Classification · 95% confidence The document is an ASX announcement dated 27 August 2025, titled 'Financial Year 2025 Preliminary Results'. It provides detailed financial performance data for the full fiscal year 2025, including net profit after tax, sales revenue, EBITDA, gross profit, and margin. It also discusses market position, international expansion, product launches, and strategic outlook. The document contains substantive financial data and analysis for the full fiscal year, not just a brief summary or announcement of a report. It is not a short announcement stating a report is attached or published, nor is it a certification or attestation. Therefore, it fits the definition of an Annual Report (10-K) or equivalent comprehensive yearly financial report. Given it is a preliminary results announcement with detailed financials for the full year, the best classification is Annual Report (10-K). FY 2025
2025-08-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.